These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 18346825)

  • 1. Meige syndrome: a rare form of cranial dystonia that was treated successfully with botulinum toxin.
    Sabesan T
    Br J Oral Maxillofac Surg; 2008 Oct; 46(7):588-90. PubMed ID: 18346825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum A toxin treatment for blepharospasm and Meige syndrome: report of 100 patients.
    Poungvarin N; Devahastin V; Chaisevikul R; Prayoonwiwat N; Viriyavejakul A
    J Med Assoc Thai; 1997 Jan; 80(1):1-8. PubMed ID: 9078810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lidocaine tape (Penles) reduces the pain of botulinum toxin injection for Meige syndrome.
    Onguchi T; Takano Y; Dogru M; Ono M; Tsubota K
    Am J Ophthalmol; 2004 Oct; 138(4):654-5. PubMed ID: 15488799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of jaw-closing and jaw-opening idiopathic oromandibular dystonia.
    Singer C; Papapetropoulos S
    Parkinsonism Relat Disord; 2006 Mar; 12(2):115-8. PubMed ID: 16271495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, placebo-controlled, crossover clinical trial of super blue-green algae in patients with essential blepharospasm or Meige syndrome.
    Vitale S; Miller NR; Mejico LJ; Perry JD; Medura M; Freitag SK; Girkin C
    Am J Ophthalmol; 2004 Jul; 138(1):18-32. PubMed ID: 15234278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cosmetic treatments and strategies for the upper face.
    Frankel AS; Markarian A
    Facial Plast Surg Clin North Am; 2007 Feb; 15(1):31-9, vi. PubMed ID: 17317553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.
    Haussermann P; Marczoch S; Klinger C; Landgrebe M; Conrad B; Ceballos-Baumann A
    Mov Disord; 2004 Mar; 19(3):303-8. PubMed ID: 15022184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin physiology in focal hand and cranial dystonia.
    Karp BI
    Toxins (Basel); 2012 Nov; 4(11):1404-14. PubMed ID: 23202323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oromandibular dystonia and botulinum toxins].
    Van Durme B; Loeb I; Van Reck J
    Acta Stomatol Belg; 1996 Mar; 93(1):37-41. PubMed ID: 9005716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oromandibular dystonia.
    Lee KH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Oct; 104(4):491-6. PubMed ID: 17689275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adding ancillaries. Botox injections.
    Tolkoff M
    Med Econ; 2006 Feb; 83(3):55-6. PubMed ID: 16506629
    [No Abstract]   [Full Text] [Related]  

  • 12. Contralateral botulinum injections improve drinking ability and facial symmetry in patients with facial paralysis.
    Krohel GB; Cipollo CL; Gaddipati K
    Am J Ophthalmol; 2005 Mar; 139(3):540. PubMed ID: 15767069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treacher Collins syndrome: an undescribed characteristic of the condition and its management with botulinum toxin and surgery.
    Warner RM; Fagan JM; Das-Gupta R
    J Craniofac Surg; 2008 Nov; 19(6):1600-2. PubMed ID: 19098560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The medical management of masseteric hypertrophy with botulinum toxin.
    Finn S; Ryan P; Sleeman D
    J Ir Dent Assoc; 2000; 46(3):84-6. PubMed ID: 11323940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on botulinum toxin.
    Flynn TC
    Semin Cutan Med Surg; 2006 Sep; 25(3):115-21. PubMed ID: 17055389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin A in the treatment of adherence syndrome.
    Ozkan SB; Kir E; Dayanir V; Dündar SO
    Ophthalmic Surg Lasers Imaging; 2003; 34(5):391-5. PubMed ID: 14509463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smothering dystonia in a patient with oromandibular dystonia.
    Grill S
    Mov Disord; 2004 Nov; 19(11):1374-5. PubMed ID: 15389989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin as therapeutic agent in local hyperhydrosis.
    Jain S; Tamer SK; Hiran S
    J Assoc Physicians India; 2002 Feb; 50():273-4. PubMed ID: 12038664
    [No Abstract]   [Full Text] [Related]  

  • 19. [Consensus recommendations on the use of botulinum toxin type A in aesthetic medicine].
    Sommer B; Bergfeld D; Sattler G
    J Dtsch Dermatol Ges; 2007 Feb; 5 Suppl 1():S1-S29. PubMed ID: 17229195
    [No Abstract]   [Full Text] [Related]  

  • 20. Anatomic considerations for treatment with botulinum toxin.
    Petrus GM; Lewis D; Maas CS
    Facial Plast Surg Clin North Am; 2007 Feb; 15(1):1-9, v. PubMed ID: 17317550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.